Hence, the increase in Akt1/2/3 phosphorylation after cetuximab treatment in the AcqRes HNSCC cell lines, detected with protein phosphorylation profiling, was confirmed with western blot (Figure 2C). This evidence concerns the gene AKT1 and head and neck squamous cell carcinoma.